Essais liés3clinical trials
VilleMar del Platalocalisation
PaysArgentinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06211764

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
TAR-200 Cancer Phase 3 NCT06211764 SunRISe-5 — A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) ACTIVE_NOT_RECRUITING
Eptinezumab Migraine Phase 3 NCT05164172 REJOIN — A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine RECRUITING
Eptinezumab Migraine Phase 3 NCT04965675 PROSPECT-2 — A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine RECRUITING